Last reviewed · How we verify
Nucleo CMP Forte
Nucleo CMP Forte is a nucleotide-based supplement designed to support cellular energy metabolism and immune function through provision of cytidine monophosphate and related nucleotide precursors.
Nucleo CMP Forte is a nucleotide-based supplement designed to support cellular energy metabolism and immune function through provision of cytidine monophosphate and related nucleotide precursors. Used for Immune system support and enhancement, Cellular energy metabolism support.
At a glance
| Generic name | Nucleo CMP Forte |
|---|---|
| Also known as | Nucleoforte |
| Sponsor | Sherief Abd-Elsalam |
| Drug class | Nucleotide supplement |
| Target | Nucleotide metabolism pathways; cellular energy (ATP) production |
| Modality | Small molecule |
| Therapeutic area | Immunology; Nutritional support |
| Phase | Phase 3 |
Mechanism of action
The drug supplies exogenous nucleotides (particularly cytidine monophosphate) that serve as building blocks for nucleic acid synthesis and cofactors in cellular energy pathways. This supplementation is intended to enhance ATP production, support rapid cell division in immune cells, and improve overall cellular function, particularly in conditions of metabolic stress or immune compromise.
Approved indications
- Immune system support and enhancement
- Cellular energy metabolism support
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Nucleo CMP Forte CI brief — competitive landscape report
- Nucleo CMP Forte updates RSS · CI watch RSS
- Sherief Abd-Elsalam portfolio CI